Joanne M. Ferrell

Joanne M. Ferrell

“Adverse drug reactions are leading causes of morbidity and mortality. Nerac partners with clients to develop and implement pharmacovigilance strategies. We understand our clients’ need for programs that meet regulatory requirements and protect patients.”
Print this page

Analyst Joanne M. Ferrell assists pharmaceutical companies and contract research organizations (CROs) comply with regulatory agency requirements. In particular, she helps companies develop and initiate programs and monitoring systems to ensure comprehensive and efficient methods of pharmaceutical adverse event monitoring for pharmacovigilant requirements.

Ms. Ferrell assists CROs with alternatives for animal model research as required by IACUC and OLAW, and she provides insight and analysis regarding toxicology, clinical trials, pharmacokinetics, and intellectual property. She partners with medical, nutraceutical, pharmaceutical, animal health and biological companies to assess R&D strategies and competitive market information.

Ms. Ferrell has nearly 20 years of experience at clinical research centers including Michigan State University Clinical Center, where she worked in weekly clinics held for oncology, allergy, and infertility, as well as disorders of hematology and coagulation. Ms. Ferrell’s areas of expertise include pharmaceuticals, toxicology, herbs, nutraceuticals, wound healing, animal health, disease models, microbiology, infection control, blood banking, clinical laboratory analysis, quality control, and instrumentation.

She holds a bachelor’s degree in medical technology from Salve Regina College and is a member of the American Society of Clinical Pathologists.

Credentials

  • B.S., Medical Technology, Salve Regina College
  • Member, American Society of Clinical Pathologists

Publications

Go Back Back To Top

ARTICLES

Think Negative | Wound Therapy Could Save Billions in Healthcare Costs

Treating the more than 2.8 million patients with chronic wounds costs billions of dollars per year, just in the United States, posing a continual challenge in medicine. One approach, negative pressure wound therapy, presents the medical device industry with an opportunity to meet that challenge.


Drug Manufacturers Should Seek Outside Services to Monitor Adverse Events

The drug safety scandals of the last few years have drawn much public scrutiny and argue strongly for the need for impartial review of adverse drug events.

INDUSTRY REPORTS

Pharmacovigilance: Staying Compliant is Critical

SAMPLE DELIVERABLES

Sample Report | Pharmacovigilance Alert for Antibody Drug Conjugates

CONTACT

Joanne M. Ferrell Nerac
  • One Technology Drive
  • Tolland, CT 06084